Philips Wins $33.7M ARPA-H Award for Robotic Stroke Care
Cambridge, Massachusetts, United States & Amsterdam, Netherlands, Aug 26, 2026 Royal Philips has received an award of up to...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Cambridge, Massachusetts, United States & Amsterdam, Netherlands, Aug 26, 2026 Royal Philips has received an award of up to...
VELIZY-VILLACOUBLAY, France, July 23, 2026 Dassault Systèmes has expanded its 3DEXPERIENCE AI-native agentic platform with the launch of three...
NEW YORK, N.Y., July 23, 2026 Apertura Gene Therapy has announced its participation in a consortium selected to receive...
LOS ANGELES, July 21, 2026 City of Hope has launched the national Phase 2 IMMUNO-BIOMAP clinical trial to better...
BAR HARBOR, Maine, USA, July 9, 2026 The Jackson Laboratory (JAX), in collaboration with the Broad Institute and a...
PHILADELPHIA, Pennsylvania, USA, July 9, 2026 GEMMA Biotherapeutics (GEMMABio) has been awarded funding from the Advanced Research Projects Agency...
Paris, France, April 7, 2026 Phase 2 Success Across Respiratory Indications In a major advancement for respiratory disease therapeutics,...
Boulder, Colorado, USA, April 6, 2026 $33.5M ARPA-H Funding Accelerates Regenerative Pipeline In a major boost to regenerative medicine...
